Option Care Health, Inc. $OPCH Shares Sold by Villere ST Denis J & Co. LLC

Villere ST Denis J & Co. LLC lowered its position in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 3.6% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 801,040 shares of the company’s stock after selling 30,085 shares during the period. Option Care Health accounts for approximately 2.4% of Villere ST Denis J & Co. LLC’s portfolio, making the stock its 23rd largest position. Villere ST Denis J & Co. LLC’s holdings in Option Care Health were worth $21,564,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Royal Bank of Canada lifted its holdings in Option Care Health by 20.7% during the 1st quarter. Royal Bank of Canada now owns 231,161 shares of the company’s stock worth $8,078,000 after buying an additional 39,661 shares during the last quarter. AQR Capital Management LLC increased its holdings in shares of Option Care Health by 162.6% in the 1st quarter. AQR Capital Management LLC now owns 41,633 shares of the company’s stock valued at $1,450,000 after acquiring an additional 25,777 shares during the last quarter. Empowered Funds LLC acquired a new stake in shares of Option Care Health during the 1st quarter worth about $208,000. Invesco Ltd. raised its position in shares of Option Care Health by 2.7% during the 2nd quarter. Invesco Ltd. now owns 294,363 shares of the company’s stock worth $9,561,000 after acquiring an additional 7,678 shares in the last quarter. Finally, EverSource Wealth Advisors LLC lifted its stake in Option Care Health by 528.1% during the second quarter. EverSource Wealth Advisors LLC now owns 1,407 shares of the company’s stock worth $46,000 after purchasing an additional 1,183 shares during the last quarter. 98.05% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities analysts have commented on OPCH shares. The Goldman Sachs Group started coverage on shares of Option Care Health in a research note on Monday, June 8th. They issued a “neutral” rating and a $22.00 price target on the stock. Zacks Research upgraded shares of Option Care Health from a “strong sell” rating to a “hold” rating in a research note on Monday, July 6th. Weiss Ratings downgraded shares of Option Care Health from a “hold (c)” rating to a “hold (c-)” rating in a research note on Monday, May 11th. Bank of America lowered Option Care Health from a “buy” rating to a “neutral” rating and set a $22.00 price objective on the stock. in a report on Friday, May 1st. Finally, JPMorgan Chase & Co. reduced their target price on Option Care Health from $40.00 to $33.00 and set an “overweight” rating for the company in a report on Monday, May 4th. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and five have given a Hold rating to the company. According to MarketBeat, Option Care Health has an average rating of “Moderate Buy” and an average price target of $30.54.

Option Care Health Stock Performance

NASDAQ:OPCH traded down $0.10 during trading hours on Friday, reaching $21.57. 1,803,038 shares of the company’s stock were exchanged, compared to its average volume of 2,424,430. Option Care Health, Inc. has a 1-year low of $18.01 and a 1-year high of $36.80. The company has a quick ratio of 1.07, a current ratio of 1.64 and a debt-to-equity ratio of 0.85. The firm has a market capitalization of $3.39 billion, a price-to-earnings ratio of 16.72, a P/E/G ratio of 1.20 and a beta of 0.65. The company has a 50-day moving average of $21.03 and a 200 day moving average of $27.87.

Option Care Health (NASDAQ:OPCH) last announced its earnings results on Thursday, April 30th. The company reported $0.40 earnings per share for the quarter, topping the consensus estimate of $0.37 by $0.03. The business had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.39 billion. Option Care Health had a net margin of 3.64% and a return on equity of 18.17%. The business’s quarterly revenue was up 1.3% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.40 earnings per share. Option Care Health has set its FY 2026 guidance at 1.820-1.920 EPS. Research analysts anticipate that Option Care Health, Inc. will post 1.64 EPS for the current year.

Insiders Place Their Bets

In related news, CEO John Charles Rademacher bought 12,500 shares of the company’s stock in a transaction dated Monday, May 4th. The shares were acquired at an average price of $21.18 per share, with a total value of $264,750.00. Following the completion of the acquisition, the chief executive officer owned 695,152 shares in the company, valued at approximately $14,723,319.36. This trade represents a 1.83% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Timothy P. Sullivan purchased 24,154 shares of the business’s stock in a transaction dated Thursday, May 7th. The shares were bought at an average price of $20.69 per share, with a total value of $499,746.26. Following the purchase, the director directly owned 73,383 shares of the company’s stock, valued at approximately $1,518,294.27. The trade was a 49.06% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. In the last ninety days, insiders purchased 73,264 shares of company stock valued at $1,548,316. 1.70% of the stock is owned by company insiders.

Option Care Health Company Profile

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.